Globalization of Clinical Trials: Ethics and ConductAnkit Lodha*
Amgen, 1 Amgen Center Drive, Thousand Oaks CA 91320, USA
- Corresponding Author:
- Ankit Lodha
Amgen, 1 Amgen Center Drive
Thousand Oaks CA 91320, USA
E-mail: [email protected]
Received Date: May 10, 2016; Accepted Date: May 17, 2016; Published Date: May 24, 2016
Citation: Lodha A (2016) Globalization of Clinical Trials: Ethics and Conduct. J Biotechnol Biomater 6:229. doi:10.4172/2155-952X.1000229
Copyright: © 2016 Lodha A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The underlying motif of the article “Ethical and Scientific Implications of the Globalization of Clinical Research” is that the clinical trials conducted in developing countries are justified; and that the suggested changes for improvement in the ethical standards can safeguard the interests of people in those areas. However, through this response, I contend that the conduction of clinical trials by pharmaceutical companies from the developed world in underdeveloped nations is essentially unethical from a pragmatic ground-level view as well as in the realms of philosophical theory.